Exabis Library
Welcome to the e-CCO Library!
DOP75: Effectiveness and Safety of tofacitinib versus vedolizumab in Patients with Ulcerative Colitis; A Nationwide, ICC Registry study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP75: Loss-of-response and immunogenicity following immunomodulator withdrawal from anti-tumour necrosis factor alpha combination therapy: Results from a large retrospective cohort study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP75: Surgery and hospitalisations rates in inflammatory bowel disease patients in the Québec provincial database from 199–6 to 2015
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP75: Video capsule endoscopy may detect active small bowel Crohn's disease requiring change of treatment despite unremarkable ileo-colonic anastomosis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP76 Corticosteroid sparing effects of ustekinumab therapy for ulcerative colitis through 2 years: UNIFI long-term extension
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP76: Comparison of healing of complex perianal Crohn´s disease fistulas by advancement flap and mesenchymal stem cell therapy
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP76: No durable impact of COVID-19 on disease activity and microbiome composition in patients with IBD
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP76: Prevalence and healthcare costs of perianal fistulas in Crohn’s disease in a nationwide cohort
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP76: Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP77 Ustekinumab is associated with better effectiveness outcomes when compared with vedolizumab in Crohn’s disease patients with prior anti-TNF failure: comparative effectiveness study from the ICC Registry
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP77: Comparative real-world effectiveness and persistence of vedolizumab versus anti-TNF therapy in biologic-naïve patients with Crohn´s Disease with Propensity Score adjustment: Maintenance phase results at week-52 from the prospective VEDOIBD study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP77: Effect of Inflammatory Bowel Disease and Related Medications on COVID-19 Incidence, Disease Severity, and Outcome -The Israeli Experience
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP77: Is durable remission achievable after ileocolic resection for Crohn's disease ? Long-term results of a prospective multicentric cohort study of the GETAID Chirurgie
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP77: The effectiveness of combination therapy mesenchymal stromal cells and certolizumab pegol in perianal lesions in Crohn's disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP78 Intestinal surgery rates in ulcerative colitis and Crohn’s disease in the era of biologics: A Danish Nationwide Register Study from 2003 to 2016
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP78: Comparative study of the effectiveness of vedolizumab versus ustekinumab after anti-TNF failure (VERSUS-CD)
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP78: Does KONO-S anastomosis reduce recurrence in Crohn's disease compared to conventional ileocolonic anastomosis ? A nationwide propensity score-matched study from GETAID Chirurgie Group (KoCoRICCO study).
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP78: Efficacy of vedolizumab in perianal Crohn’s disease: the BioLAP multi-centre observational study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP78: The differential diagnosis and clinicopathological spectrum of Inflammatory Bowel Disease: An interesting and informative ECCO topical review
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP79 Dose escalation of upadacitinib in Crohn’s disease patients with an inadequate response: Data from the randomised CELEST study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM